ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development Clinical oncology diagnostics veteran Kevin Keegan appointed president and chief operating officer SAN DIEGO — May 27, 2026 — ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, today announced the close of $52 […] The post ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection appeared first on ClearNote Health .